dermatology assets

Astellas Looks to Sell Dermatology Assets

Japan's Astellas Pharma looks to sell its dermatology portfolio valued between US$500 million to US$1 billion.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics